DOI QR코드

DOI QR Code

Methimazole-Induced Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in the Peripheral Nerves

  • Kang, Mi Il (Department of Internal Medicine, Dankook University College of Medicine) ;
  • Kim, Dohee (Department of Internal Medicine, Dankook University College of Medicine)
  • Received : 2018.03.17
  • Accepted : 2018.05.24
  • Published : 2018.11.30

Abstract

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis has been reported in Graves' disease patients treated with antithyroid drugs (ATDs), especially propylthiouracil. ATD-induced ANCA-associated vasculitis usually involved the kidneys followed by the respiratory organs and skin. The treatment of ANCA-associated vasculitis induced by ATDs is to stop ATD therapy immediately, which often leads to an overall good prognosis. We report a case of ANCA-associated vasculitis in the peripheral nerves of the lower extremities in a 66-year-old woman who was treated with methimazole (MMI) for Graves' disease. To our knowledge, this is the third case of peripheral nervous system (PNS) involvement of ATD-induced vasculitis and the first case of PNS vasculitis associated with MMI.

Keywords

References

  1. Brent GA. Clinical practice. Graves' disease. N Engl J Med 2008;358(24):2594-605. https://doi.org/10.1056/NEJMcp0801880
  2. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011;21(6):593-646. https://doi.org/10.1089/thy.2010.0417
  3. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352(9):905-17. https://doi.org/10.1056/NEJMra042972
  4. Shikha D, Harris J, Resta C, Park P. Antineutrophilic cytoplasmic antibody positive vasculitis associated with methimazole use. Case Rep Endocrinol 2015;2015:530319.
  5. Balavoine AS, Glinoer D, Dubucquoi S, Wemeau JL. Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem? Thyroid 2015;25(12):1273-81. https://doi.org/10.1089/thy.2014.0603
  6. Bilge NS, Kasifoglu T, Korkmaz C. PTU-induced ANCA-positive vasculitis: an innocent or a life-threatening adverse effect? Rheumatol Int 2013;33(1):117-20. https://doi.org/10.1007/s00296-011-2280-5
  7. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005;7(5):R1072-81. https://doi.org/10.1186/ar1789
  8. Noh JY, Yasuda S, Sato S, Matsumoto M, Kunii Y, Noguchi Y, et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab 2009;94(8):2806-11. https://doi.org/10.1210/jc.2008-2700
  9. Tripodi PF, Ruggeri RM, Campenni A, Cucinotta M, Mirto A, Lo Gullo R, et al. Central nervous system vasculitis after starting methimazole in a woman with Graves' disease. Thyroid 2008;18(9):1011-3. https://doi.org/10.1089/thy.2008.0121
  10. Leger JM, Dancea S, Brunet P, Hauw JJ. Polyneuropathy during treatment with carbimazole. Rev Neurol (Paris) 1984;140(11):652-6.
  11. Vanek C, Samuels MH. Central nervous system vasculitis caused by propylthiouracil therapy: a case report and literature review. Thyroid 2005;15(1):80-4. https://doi.org/10.1089/thy.2005.15.80
  12. Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford) 2008;47(10):1515-20. https://doi.org/10.1093/rheumatology/ken321
  13. Wang C, Gou SJ, Xu PC, Zhao MH, Chen M. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracilinduced antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Res Ther 2013;15(6):R196. https://doi.org/10.1186/ar4386